Zenas Biopharma (ZBIO) Stock Price
Zenas Biopharma Price
Revenue at Zenas Biopharma has contracted by 55.3% per year over the past 2 years to 10.00 M USD. Zenas Biopharma's net margin stands at -3,777.4%, down from -74.2% several years earlier. Analysts set a median price target of 32.00 USD, implying 21.8% above the current price. Of 14 analysts, 12 rate the stock a buy — an overall Buy consensus.
Zenas Biopharma stock price
Zenas Biopharma business model & stock analysis
Frequently asked questions about Zenas Biopharma
Analysts currently set an average price target of 32.00 USD for the Zenas Biopharma stock (median: 32.00 USD), implying +21.8 % versus the latest price. The consensus is based on 14 analyst ratings.
14 analysts currently rate the Zenas Biopharma stock: 12 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Zenas Biopharma to generate revenue of 10.38 M USD and earnings per share of -6.50 USD.
Converted at the current exchange rate, the Zenas Biopharma share trades at 23.47 EUR (26.27 USD).
The expected revenue of Zenas Biopharma is 10.38 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Zenas Biopharma is -302.43 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Zenas Biopharma is currently -4.04. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Zenas Biopharma stock.
The price-to-sales ratio (P/S) of Zenas Biopharma is currently 117.63. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Zenas Biopharma stock.
The Eulerpool Quality Score for Zenas Biopharma is 3/10.
The ISIN of Zenas Biopharma is US98937L1052. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Zenas Biopharma is ZBIO. The ticker symbol is used to trade Zenas Biopharma shares on the stock exchange.
Zenas Biopharma stock
Zenas Biopharma Peer Group
All fundamentals and in-depth analysis of Zenas Biopharma
Our stock analysis for Zenas Biopharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zenas Biopharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.